title: Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
abstract: Genetic predisposition to hereditary hemochromatosis (HH) is associated with primary hypertriglyceridemia (HTG). If iron overload influences the development of HTG, the management of these patients could be different. However, the metabolic syndrome in primary HTG is frequent; and it could partially confuse the association. The objective was to determine whether periodic bloodletting could decrease triglyceride concentrations in subjects with HH and iron overload. We retrospectively studied 155 genetically defined HH patients (C282Y homozygotes and compound heterozygotes C282Y/H63D) with iron overload and under periodic therapeutic phlebotomy. Hypertriglyceridemia (triglycerides ≥150 mg/dL) was present in 49 subjects at baseline (31.6%). Phlebotomies significantly decreased triglycerides, especially in subjects with basal HTG (from 287 mg/dL at baseline to 133 mg/dL after phlebotomies, P < .001). Blood glucose and total cholesterol did not change with phlebotomies. The triglyceride-lowering effect was obtained until ferritin concentration decreased to less than 200 μg/L and transferrin saturation to less than 40%. The triglyceride-lowering effect was obtained for glucose levels both less than and greater than 100 mg/dL. In summary, HH subjects frequently have HTG that improves after therapeutic phlebotomy, independently of basal blood glucose. Our results suggest that therapeutic phlebotomy could be a useful therapeutic approach in patients with HTG and iron overload.
authors.affiliation: Unidad de Lípidos and Laboratorio de Investigacion Molecular, Hospital Universitario Miguel Servet, Instituto Aragones de Ciencias de la Salud (I + CS), 50009 Zaragoza, Spain.
authors.forename: Paola
authors.initials: P
authors.lastname: Casanova-Esteban
authors.forename: Nuria
authors.initials: N
authors.lastname: Guiral
authors.forename: Eva
authors.initials: E
authors.lastname: Andrés
authors.forename: Carmen
authors.initials: C
authors.lastname: Gonzalvo
authors.forename: Rocio
authors.initials: R
authors.lastname: Mateo-Gallego
authors.forename: Pilar
authors.initials: P
authors.lastname: Giraldo
authors.forename: Jose A
authors.initials: JA
authors.lastname: Paramo
authors.forename: Fernando
authors.initials: F
authors.lastname: Civeira
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000097:blood; D005838:Genotype; D006432:Hemochromatosis / Q000235:genetics / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D007501:Iron / Q000097:blood; D019190:Iron Overload / Q000378:metabolism; D050356:Lipid Metabolism / Q000235:genetics* / Q000502:physiology*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D018962:Phlebotomy; D012189:Retrospective Studies; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014168:Transferrin / Q000378:metabolism; D014280:Triglycerides / Q000097:blood; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D014168:Transferrin; D014280:Triglycerides; D005293:Ferritins; D007501:Iron